<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The catastrophic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (CAPS) is a life-threatening condition resulting from <z:hpo ids='HP_0003678'>rapidly progressive</z:hpo> widespread thromboses mainly affecting the microvasculature in the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Within a few days, the patients develop multiorgan failure with pulmonary distress, <z:hpo ids='HP_0000083'>renal failure</z:hpo> with severe <z:hpo ids='HP_0000822'>hypertension</z:hpo>, cerebral, cardiac, digestive or cutaneous involvement </plain></SENT>
<SENT sid="2" pm="."><plain>CAPS develops in less than 1% of patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, either primary or associated with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>CAPS reveals the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> in about 50% of cases </plain></SENT>
<SENT sid="4" pm="."><plain>CAPS may be precipitated by <z:e sem="disease" ids="C0009450" disease_type="Disease or Syndrome" abbrv="">infectious diseases</z:e>, surgical procedures or discontinuation of anticoagulation </plain></SENT>
<SENT sid="5" pm="."><plain>CAPS overall mortality rate has decreased in the past decade and is now around 30% </plain></SENT>
<SENT sid="6" pm="."><plain>Within our hospital, it has been reduced to 10% </plain></SENT>
<SENT sid="7" pm="."><plain>The main differential diagnoses are other <z:e sem="disease" ids="C0034155" disease_type="Disease or Syndrome" abbrv="">thrombotic microangiopathies</z:e>, and <z:hpo ids='HP_0011874'>heparin-induced thrombocytopenia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>The treatment of CAPS consists of the empirical association of anticoagulation and <z:chebi fb="0" ids="50858">corticosteroids</z:chebi>, plus plasma exchange or intravenous immunoglobulins </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="4027">Cyclophosphamide</z:chebi> is added in patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>The prevention of CAPS is based upon the adequate management of the perioperative period when surgery cannot be avoided, the prompt treatment of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> and the education of patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
</text></document>